🔓 Unlock the full profile of Paul Gilbert (Wcg Medavante-Prophase), including verified contact details, financial insights, and professional associations.
See Paul Gilbert Full ProfileBelow are the ✅ Verified Contact Details to help you connect directly:
Email: pau*****@wcg******.com
Mobile: 72411*****
Estimated Net Worth 💰 : ₹0 – ₹500+ Cr (approx. $0 – $60M)
Key Insights You Should Know About This Individual
- Paul Gilbert serves as the CEO and Co-Founder of WCG MedAvante-ProPhase, a company established in 2002 that specializes in the development of technologies and services for clinical trials.
- Under Gilbert's leadership, WCG MedAvante-ProPhase has been instrumental in improving the quality of patient data and streamlining clinical research processes.
- The organization focuses on enhancing clinical trial efficiency through innovative solutions, contributing significantly to advancements in the field of clinical research.
- WCG MedAvante-ProPhase operates with an emphasis on providing objective data, aiming to reduce variability and ensure reliability in clinical outcomes.
- The company has faced challenges, including a decline in organizational headcount growth over both six-month and twelve-month periods, indicating a need for strategic adjustments.
- WCG MedAvante-ProPhase maintains a robust online presence with a dedicated website and active LinkedIn profile, helping to engage with the clinical research community.
- The organization has developed a reputation for its commitment to high-quality standards in clinical assessments, which has enhanced its credibility in the industry.
- Through Gilbert's vision and direction, WCG MedAvante-ProPhase continues to play a critical role in advancing clinical development methodologies.